NASDAQ: ARCT
Arcturus Therapeutics Holdings Inc Stock Ownership - Who owns Arcturus Therapeutics Holdings?

Insider buying vs selling

Have Arcturus Therapeutics Holdings Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Pad ChivukulaChief Scientific Officer COO2024-10-1512,000$20.76
$249.12kSell

1 of 1

ARCT insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when ARCT insiders and whales buy or sell their stock.

ARCT Shareholders

What type of owners hold Arcturus Therapeutics Holdings Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Federated Hermes Inc17.31%4,694,060$63.56MInstitution
Blackrock Inc10.18%2,759,970$37.37MInstitution
Ark Investment Management LLC7.41%2,008,480$27.19MInstitution
Sumitomo Mitsui Trust Group Inc7.10%1,926,084$26.08MInstitution
Nikko Asset Management Americas Inc7.10%1,926,084$26.08MInstitution
Vanguard Group Inc6.45%1,748,928$23.68MInstitution
Joseph E. Payne5.46%1,480,097$20.04MInsider
Ultragenyx Pharmaceutical Inc5.16%1,400,000$18.96MInsider
State Street Corp4.72%1,280,451$17.34MInstitution
Balyasny Asset Management LP3.46%938,190$12.70MInstitution

1 of 3

ARCT vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
ARCT87.83%12.17%Net Selling
GLUE33.05%66.95%Net SellingNet Selling
HUMA39.21%22.32%Net Selling
VIGL44.05%55.95%Net Buying
INBX72.35%27.65%Net Buying

Arcturus Therapeutics Holdings Stock Ownership FAQ

Who owns Arcturus Therapeutics Holdings?

Arcturus Therapeutics Holdings (NASDAQ: ARCT) is owned by 98.07% institutional shareholders, 13.59% Arcturus Therapeutics Holdings insiders, and 0.00% retail investors. Joseph E. Payne is the largest individual Arcturus Therapeutics Holdings shareholder, owning 1.48M shares representing 5.46% of the company. Joseph E. Payne's Arcturus Therapeutics Holdings shares are currently valued at $19.98M.

If you're new to stock investing, here's how to buy Arcturus Therapeutics Holdings stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.